BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 6117169)

  • 1. Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
    Stefaneanu L; Kovacs K; Horvath E; Buchfelder M; Fahlbusch R; Lancranjan L
    Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.
    Andersen M; Hansen TB; Bollerslev J; Bjerre P; Schrøder HD; Hagen C
    J Endocrinol Invest; 1995 Dec; 18(11):840-6. PubMed ID: 8778155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered responsiveness to hypophysiotrophic hormones of perifused rat pituitary tumours.
    Carlson HE; Mariz IK; Briggs JE; Daughaday WH
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):512-22. PubMed ID: 190840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine.
    Adams EF; Brajkovich IE; Mashiter K
    J Clin Endocrinol Metab; 1979 Jul; 49(1):120-6. PubMed ID: 109461
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro effects of thyrotropin-releasing hormone and somatostatin on prolactin and growth hormone release by the pituitary of Poecilia latipinna. I. An electrophoretic study.
    Wigham T; Batten TF
    Gen Comp Endocrinol; 1984 Sep; 55(3):444-9. PubMed ID: 6147295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and prolactin secretion in hypophysial stalk-transected pigs as affected by growth hormone and prolactin-releasing and inhibiting factors.
    Anderson LL; Ford JJ; Klindt J; Molina JR; Vale WW; Rivier J
    Proc Soc Exp Biol Med; 1991 Feb; 196(2):194-202. PubMed ID: 1671298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and prolactin secretion by dispersed cell cultures of a normal human pituitary: effects of thyrotrophin releasing hormone, theophylline, somatostatin, and 2-bromo-alpha-ergocryptine.
    Adams EF; Brajkovich IE; Mashiter K
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):345-51. PubMed ID: 6117169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine profile of bromocriptine: its application in endocrine diseases.
    Lancranjan I
    J Neural Transm; 1981; 51(1-2):61-82. PubMed ID: 6455501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotrophin releasing hormone: endocrine and central effects.
    Griffiths EC
    Psychoneuroendocrinology; 1985; 10(3):225-35. PubMed ID: 2865764
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary cells in space.
    Hymer WC; Shellenberger K; Grindeland R
    Adv Space Res; 1994; 14(8):61-70. PubMed ID: 11537960
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.